TL; DR Speed, flexibility, and agility, anchored around the patient experience, fueled by digital and analytics, have become legitimate currency to generate value for big pharma. We explore 3 examples. COVID has taught Big Pharma and Life Sciences institutions a solid lesson in 2020 that will change how the sector and actors operate forever: Slow … More 45 Seconds: Agility for Big Pharma